TRAIL induces apoptosis and activation of NFκB

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 687-688

  Jeremias, Irmela ^a   Debatin, Klaus Michael ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Apoptosis; Lymphocytes; NF B; Resistance; TRAIL

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR;

APOPTOSIS; CANCER CELL; CELL DEATH; CONFERENCE PAPER; GENE INDUCTION; HUMAN; HUMAN CELL;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032440538     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Wiley S R, Schooley K, Smolak P J, Din W S, Huang C P, Nicholi J K, Sutherland G R, Smith T D, Rauch C, Smith C A, Goodwill R G. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673.
2. Pitti R M, Marsters S A, Ruppert S, Donahue C J, Moore A, Ashkenazi A. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271: 12687.
3. Jeremias I, Herr I, Boehler T, Debatin K M. 1998. TRAIL/Apo-2-ligand induced apoptosis in T cells. Eur. J. Immunol. 28: 143.
4. Gura T. 1997. How TRAIL kills cancer cells, but not normal cells. Science 277: 768.
5. Pan G, O'Rourke K, Chinnaiyan A M, Gentz R, Ebner R, Ni J, Dixit V M. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111.
6. Walczak H, Degli-Esposti M A, Johnson R S, Smolak P J, Waugh J Y, Boiani N, Timour M S, Gerhart M J, Schooley K A, Smith C A, Goodwin R G, Rauch C T. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16: 5386.
7. Sheridan J P, Marsters S A, Pitti R M, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray C L, Baker K, Wood W I, Goddard A D, Godowski P, Ashkenazi A. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818.
8. Degli-Esposti M A, Dougall W C, Smolak P J, Waugh J Y, Smith C A, Goodwin R G. 1997. The novel receptor TRAIL-R4 induces NFκB and protects against TRAIL-meditated apoptosis, yet retains an incomplete death domain. Immunity 7: 813.
9. Schneider P, Thome M, Burns K, Bodmer J L, Hofmann K, Kataoka T, Holler N, Tschopp J. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NFκB. Immunity 7: 831.
10. Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin K M. 1998. inhibition of NFκB activation attenuates apoptosis resistance in lymphoid cells. Blood 91: 4624.
11. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer J L, Schroeter M, Burns K, Mattmann C, Rimoldi D, French L E, Tschopp J. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388: 190.
12. Beg A A, Baltimore D. 1996. An essential role of NFκB in preventing TNF-α-induced cell death. Science 274: 782.
13. Ponton A, Clement M V, Stamenkovic I. 1996. The CD95 (APO-1/Fas) receptor activates NFκB independently of its cytotoxic function. J Biol. Chem. 271: 8991.
14. Das K C, White C W. 1997. Activation of NFκB by anti-neoplastic agents. J. Biol. Chem. 272: 14914.